Clinical Trial Update: Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Benmelstobart and Anlotinib in combination with chemotherapy as first-line treatment for extensive-stage small cell lung can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Benmelstobart

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Extensive-stage Small Cell Lung Cancer | Phase 4 | Status: NOT_YET_RECRUITING